| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Rajesh R Tampi, Juan Joseph Young, Deena Tamp. Behavioral symptomatology and psychopharmacology of Lewy body dementia. Handbook of clinical neurology. vol 165. 2020-04-17. PMID:31727230. |
parkinson's disease dementia (pdd) and dementia with lewy bodies (dlb) are the two main syndromes in lbd. |
2020-04-17 |
2023-08-13 |
Not clear |
| Shannon L Risacher, Andrew J Sayki. Neuroimaging in aging and neurologic diseases. Handbook of clinical neurology. vol 167. 2020-04-16. PMID:31753134. |
the spectrum covers neuroimaging measures from normal aging to a variety of dementias: late-onset alzheimer's disease [ad; including mild cognitive impairment (mci)], familial and nonfamilial early-onset ad, atypical ad syndromes, posterior cortical atrophy (pca), logopenic aphasia (lvppa), cerebral amyloid angiopathy (caa), vascular dementia (vad), sporadic and familial behavioral-variant frontotemporal dementia (bvftd), semantic dementia (sd), progressive nonfluent aphasia (pnfa), frontotemporal dementia with motor neuron disease (ftd-mnd), frontotemporal dementia with amyotrophic lateral sclerosis (ftd-als), corticobasal degeneration (cbd), progressive supranuclear palsy (psp), dementia with lewy bodies (dlb), parkinson's disease (pd) with and without dementia, and multiple systems atrophy (msa). |
2020-04-16 |
2023-08-13 |
Not clear |
| Kazunari Ishi. Diagnostic imaging of dementia with Lewy bodies, frontotemporal lobar degeneration, and normal pressure hydrocephalus. Japanese journal of radiology. vol 38. issue 1. 2020-04-13. PMID:31549279. |
this review summarizes the neuroimaging findings of dementia with lewy bodies (dlb), frontotemporal lobar degeneration (ftld), and normal pressure hydrocephalus (nph). |
2020-04-13 |
2023-08-13 |
Not clear |
| Elena Rodriguez-Vieitez, Henrietta M Nielse. Associations Between APOE Variants, Tau and α-Synuclein. Advances in experimental medicine and biology. vol 1184. 2020-04-08. PMID:32096038. |
while tau is a hallmark of alzheimer's disease (ad) and other non-ad tauopathies, and α-synuclein is the pathological feature of the spectrum of synucleinopathies including parkinson's disease (pd), parkinson's disease with dementia (pdd) and dementia with lewy bodies (dlb), the presence of co-pathologies is very frequent in all these diseases. |
2020-04-08 |
2023-08-13 |
human |
| Ana Fernández-Arcos, Estrella Morenas-Rodríguez, Joan Santamaria, Raquel Sánchez-Valle, Albert Lladó, Carles Gaig, Alberto Lleó, Alex Iranz. Clinical and video-polysomnographic analysis of rapid eye movement sleep behavior disorder and other sleep disturbances in dementia with Lewy bodies. Sleep. vol 42. issue 7. 2020-04-06. PMID:30946468. |
the main objective of this study was to study rapid eye movement (rem) sleep behavior disorder (rbd) and other sleep disorders in dementia with lewy bodies (dlb). |
2020-04-06 |
2023-08-13 |
Not clear |
| Kunikazu Tanji, Yasuo Miki, Fumiaki Mori, Tomoya Kon, Akiyoshi Kakita, Hitoshi Takahashi, Koichi Wakabayash. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy. Brain pathology (Zurich, Switzerland). vol 29. issue 6. 2020-04-06. PMID:31006160. |
we previously reported that nub1 is highly involved in the pathogenesis of synucleinopathy including parkinson's disease (pd), dementia with lewy bodies (dlb) and multiple system atrophy (msa). |
2020-04-06 |
2023-08-13 |
Not clear |
| Yuki Ozaki, Yuta Yoshino, Kiyohiro Yamazaki, Shinichiro Ochi, Jun-Ichi Iga, Masahiro Nagai, Masahiro Nomoto, Shu-Ichi Uen. DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's disease. Acta neurologica Scandinavica. vol 141. issue 2. 2020-04-03. PMID:31659741. |
the aim was to clarify whether drd2 methylation changes in leukocytes of dementia with lewy bodies (dlb) or parkinson's disease (pd) patients are seen and can be used to discriminate between them. |
2020-04-03 |
2023-08-13 |
Not clear |
| Yari Carlomagno, Dah-Eun Chloe Chung, Mei Yue, Aishe Kurti, Nicole M Avendano, Monica Castanedes-Casey, Kelly M Hinkle, Karen Jansen-West, Lillian M Daughrity, Jimei Tong, Virginia Phillips, Rosa Rademakers, Michael DeTure, John D Fryer, Dennis W Dickson, Leonard Petrucelli, Casey Coo. Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant. Acta neuropathologica communications. vol 7. issue 1. 2020-04-02. PMID:30674342. |
pathogenic mutations in the tau gene (microtubule associated protein tau, mapt) are linked to the onset of tauopathy, but the a152t variant is unique in acting as a risk factor for a range of disorders including alzheimer's disease (ad), progressive supranuclear palsy (psp), corticobasal degeneration (cbd), and dementia with lewy bodies (dlb). |
2020-04-02 |
2023-08-13 |
mouse |
| Daichi Shigemizu, Shintaro Akiyama, Yuya Asanomi, Keith A Boroevich, Alok Sharma, Tatsuhiko Tsunoda, Takashi Sakurai, Kouichi Ozaki, Takahiro Ochiya, Shumpei Niid. A comparison of machine learning classifiers for dementia with Lewy bodies using miRNA expression data. BMC medical genomics. vol 12. issue 1. 2020-04-02. PMID:31666070. |
dementia with lewy bodies (dlb) is the second most common subtype of neurodegenerative dementia in humans following alzheimer's disease (ad). |
2020-04-02 |
2023-08-13 |
Not clear |
| Silvia Paola Caminiti, Arianna Sala, Leonardo Iaccarino, Luca Beretta, Andrea Pilotto, Luigi Gianolli, Sandro Iannaccone, Giuseppe Magnani, Alessandro Padovani, Luigi Ferini-Strambi, Daniela Peran. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria. Alzheimer's research & therapy. vol 11. issue 1. 2020-03-30. PMID:30797240. |
the utility of [18f]fdg-pet in dementia with lewy bodies (dlb) needs further validation by considering large samples of patients and disease comparisons and applying state-of-the-art statistical methods. |
2020-03-30 |
2023-08-13 |
Not clear |
| Alon Seifan, Christine A Ganzer, Krista Ryon, Michael Lin, Rahman Mahmudur, Henriquez Adolfo, Cindy Shih, Alan R Jacobs, Molly Greenwald, Richard S Isaacso. Detecting Non-cognitive Features of Prodromal Neurodegenerative Diseases. Current aging science. vol 11. issue 4. 2020-03-30. PMID:30845903. |
prodromal neurodegenerative disease (nd) due to tauopathies such as alzheimer's disease (ad) and synucleinopathies (sn) such as parkinson's disease (pd) and dementia with lewy bodies (dlb) present subtly. |
2020-03-30 |
2023-08-13 |
Not clear |
| Bethany Peterson, Melissa Armstrong, Douglas Galasko, James E Galvin, Jennifer Goldman, David Irwin, Henry Paulson, Daniel Kaufer, James Leverenz, Angela Lunde, Ian G McKeith, Andrew Siderowf, Angela Taylor, Katherine Amodeo, Matt Barrett, Kimiko Domoto-Reilly, John Duda, Stephen Gomperts, Neill Graff-Radford, Samantha Holden, Lawrence Honig, Daniel Huddleston, Carol Lippa, Irene Litvan, Carol Manning, Karen Marder, Charbel Moussa, Chiadi Onyike, Fernando Pagan, Alexander Pantelyat, Victoria Pelak, Kathleen Poston, Joseph Quinn, Irene Richard, Liana S Rosenthal, Marwan Sabbagh, Douglas Scharre, Sharon Sha, Holly Shill, Yasar Torres-Yaghi, Tina Christie, Todd Graham, Ian Richards, Mike Koehler, Brad Boev. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's research & therapy. vol 11. issue 1. 2020-03-30. PMID:30867052. |
the program was established to increase patient access to clinical experts on lewy body dementia (lbd), which includes dementia with lewy bodies (dlb) and parkinson's disease dementia (pdd), and to create a clinical trials-ready network. |
2020-03-30 |
2023-08-13 |
Not clear |
| Vanshika Gupta, Ritu Verma, Rajeev Ranjan, Ethel S Belho, Nikhil Seniaray, Veronique Dinand, Dharmender Malik, Harsh Mahaja. Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia. Nuclear medicine communications. vol 40. issue 12. 2020-03-27. PMID:31633646. |
to study the imaging patterns of posterior cortical atrophy (pca) and dementia with lewy bodies (dlb) on fluoro-deoxyglucose positron emission tomography computed tomography ([f]fdg pet/ct), identify areas of overlap and differences and to develop a prediction model to assist in diagnosis using univariate and multivariate analysis. |
2020-03-27 |
2023-08-13 |
Not clear |
| Nahid Olfati, Ali Shoeibi, Irene Litva. Progress in the treatment of Parkinson-Plus syndromes. Parkinsonism & related disorders. vol 59. 2020-03-26. PMID:30314846. |
progressive supranuclear palsy (psp), corticobasal degeneration (cbd), multiple system atrophy (msa), and dementia with lewy bodies (dlb) are the four major proteinopathic neurodegenerative disorders. |
2020-03-26 |
2023-08-13 |
human |
| Roongroj Bhidayasiri, Jirada Sringean, Stephen G Reich, Carlo Colosim. Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders. Parkinsonism & related disorders. vol 59. 2020-03-26. PMID:30409560. |
here, we have conducted a systematic review to identify red flags and their clinical evidence in the differential diagnosis of common degenerative parkinsonism, including pd, msa, progressive supranuclear palsy (psp), corticobasal degeneration (cbd), and dementia with lewy body (dlb). |
2020-03-26 |
2023-08-13 |
Not clear |
| Alan J Thomas, Paul Donaghy, Gemma Roberts, Sean J Colloby, Nicky A Barnett, George Petrides, Jim Lloyd, Kirsty Olsen, John-Paul Taylor, Ian McKeith, John T O'Brie. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies. Psychological medicine. vol 49. issue 3. 2020-03-23. PMID:29692275. |
dopaminergic imaging has high diagnostic accuracy for dementia with lewy bodies (dlb) at the dementia stage. |
2020-03-23 |
2023-08-13 |
Not clear |
| Lauren Walker, Leonidas Stefanis, Johannes Attem. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions. Journal of neurochemistry. vol 150. issue 5. 2020-03-23. PMID:30892688. |
inclusive of parkinson's disease (pd), parkinson's disease dementia (pdd) and dementia with lewy bodies (dlb), controversy still exists as to whether they should be considered as separate disease entities or as part of the same disease continuum. |
2020-03-23 |
2023-08-13 |
Not clear |
| Kejal Kantarci, Val J Lowe, Qin Chen, Scott A Przybelski, Timothy G Lesnick, Christopher G Schwarz, Matthew L Senjem, Jeffrey L Gunter, Clifford R Jack, Jonathan Graff-Radford, David T Jones, David S Knopman, Neill Graff-Radford, Tanis J Ferman, Joseph E Parisi, Dennis W Dickson, Ronald C Petersen, Bradley F Boeve, Melissa E Murra. β-Amyloid PET and neuropathology in dementia with Lewy bodies. Neurology. vol 94. issue 3. 2020-03-23. PMID:31862783. |
β-amyloid (aβ) pathology is common in patients with probable dementia with lewy bodies (dlb). |
2020-03-23 |
2023-08-13 |
Not clear |
| Astrid Melani Suantio, Hian Liang Huang, Cecilia Sze Nga Kwok, Darren Cheng Han Teo, Minh Ha Nguye. FDG-PET in suspected dementia with Lewy bodies: a case report. BMC geriatrics. vol 19. issue 1. 2020-03-16. PMID:31138141. |
dementia with lewy bodies (dlb) is still underdiagnosed or mistaken for other types of neurodegenerative diseases. |
2020-03-16 |
2023-08-13 |
Not clear |
| Toril Marie Terum, Ingelin Testad, Arvid Rongve, Dag Aarsland, Ellen Svendsboe, John Roger Anderse. The association between specific neuropsychiatric disturbances in people with Alzheimer's disease and dementia with Lewy bodies and carer distress. International journal of geriatric psychiatry. vol 34. issue 10. 2020-03-13. PMID:31050041. |
the aim of this study was to determine whether specific neuropsychiatric disturbances in people with alzheimer disease (ad) and dementia with lewy bodies (dlb) differentially impact carer distress. |
2020-03-13 |
2023-08-13 |
Not clear |